BSX
BOSTON SCIENTIFIC CORP
NYSE · Healthcare · Medical - Devices · US
$43.34
−0.48%Forward multiples
Based on analyst estimates
- P/E forward
- 13.18x
- P/E 2026E
- 13.23x
- P/E 2027E
- 12.74x
- P/E 2028E
- 11.50x
- P/S forward
- 2.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.48x
- PEG TTM
- 0.54x
- Price / book
- 2.52x
- Price / sales
- 2.99x
- Price / cash flow
- 13.87x
Enterprise value
- Enterprise value
- $75.1B
- EV / sales
- 3.58x
- EV / EBITDA
- 13.23x
- EV / EBIT
- 16.67x
- Market cap
- $62.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026